A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore Structure (*)

  1. Heather K. B. Simmerman(1),
  2. Yvonne M. Kobayashi(2),
  3. Joseph M. Autry(2) and
  4. Larry R. Jones(2)(§)
  1. From the (1)Repligen Corporation, Cambridge, Massachusetts 02139 and the
  2. (2)Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202
  1. § To whom correspondence and reprint requests should be addressed:
    Krannert Institute of Cardiology, 1111 W. 10th St., Indianapolis, IN 46202
    . Tel.: 317-630-6695; Fax: 317-630-8595.

Abstract

Phospholamban is a phosphoprotein regulator of cardiac sarcoplasmic reticulum which is phosphorylated in response to β-adrenergic stimulation. Previous results have shown that phospholamban forms CaGraphic-selective channels in lipid bilayers. The channel-forming domain has been localized to amino acid residues 26-52, which form a stable pentameric, helical structure. The specific residues responsible for stabilizing the pentameric membrane domain of phospholamban have been identified by mutational analysis. Residues 26-52 were individually mutated to Ala or Phe, and the ability of the resulting mutant to form a pentamer or other oligomer was assessed by SDS-polyacrylamide gel electrophoresis analysis. Replacement of LeuGraphic, IleGraphic, LeuGraphic, IleGraphic, or LeuGraphic by Ala prevented pentamer formation, indicating their essential involvement in the oligomeric assembly. The heptad repeats, and 3-4-residue spacing of the essential amino acids suggest that residues 37-52 adopt a pentameric coiled-coil structure stabilized by a leucine zipper motif formed by the close packing of LeuGraphic, IleGraphic, LeuGraphic, IleGraphic, and LeuGraphic. The resulting symmetric structure contains a central pore defined by the hydrophobic surface of the five stabilizing leucine zippers, which are oriented to the interior and form the backbone of the pentamer.

Footnotes

  • * This work was supported by National Institutes of Health Grants HL06308 and HL49428. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    PLB

    phospholamban

    PAGE

    polyacrylamide gel electrophoresis

    SR

    sarcoplasmic reticulum.

    • Received October 5, 1995.
    • Revision received January 2, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement